Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP865902.RAUwjvGFK22bYphtDIDHII2TFAdbeMoB9ukc7e6BXVICE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP865902.RAUwjvGFK22bYphtDIDHII2TFAdbeMoB9ukc7e6BXVICE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP865902.RAUwjvGFK22bYphtDIDHII2TFAdbeMoB9ukc7e6BXVICE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP865902.RAUwjvGFK22bYphtDIDHII2TFAdbeMoB9ukc7e6BXVICE130_provenance.
- NP865902.RAUwjvGFK22bYphtDIDHII2TFAdbeMoB9ukc7e6BXVICE130_assertion description "[The discovery of two major podocyte antigens, neutral endopeptidase (NEP), involved in rare cases of neonatal membranous nephropathy, and the M-type phospholipase A2 receptor 1 (PLA2R1), the first antigen discovered in adults, have been major 'breakthroughs' in our understanding of the pathogenesis of human membranous nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP865902.RAUwjvGFK22bYphtDIDHII2TFAdbeMoB9ukc7e6BXVICE130_provenance.
- NP865902.RAUwjvGFK22bYphtDIDHII2TFAdbeMoB9ukc7e6BXVICE130_assertion evidence source_evidence_literature NP865902.RAUwjvGFK22bYphtDIDHII2TFAdbeMoB9ukc7e6BXVICE130_provenance.
- NP865902.RAUwjvGFK22bYphtDIDHII2TFAdbeMoB9ukc7e6BXVICE130_assertion SIO_000772 22240444 NP865902.RAUwjvGFK22bYphtDIDHII2TFAdbeMoB9ukc7e6BXVICE130_provenance.
- NP865902.RAUwjvGFK22bYphtDIDHII2TFAdbeMoB9ukc7e6BXVICE130_assertion wasDerivedFrom befree-20150227 NP865902.RAUwjvGFK22bYphtDIDHII2TFAdbeMoB9ukc7e6BXVICE130_provenance.
- NP865902.RAUwjvGFK22bYphtDIDHII2TFAdbeMoB9ukc7e6BXVICE130_assertion wasGeneratedBy ECO_0000203 NP865902.RAUwjvGFK22bYphtDIDHII2TFAdbeMoB9ukc7e6BXVICE130_provenance.
- befree-20150227 importedOn "2015-02-27" NP865902.RAUwjvGFK22bYphtDIDHII2TFAdbeMoB9ukc7e6BXVICE130_provenance.